InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength

Go back to InterMune (ITMN) Could Draw Bids as IPF Treatment Esbriet Gains Strength
Gilead Sciences (NASDAQ: GILD) Delayed: 135.87 +0.10 (0.07%)
Previous Close $135.77    52 Week High $108.63 
Open $133.99    52 Week Low $71.39 
Day High $137.12    P/E 75.07 
Day Low $133.30    EPS $1.81 
Volume 5,684,004       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 50.30 -0.6 (1.18%)
Previous Close $50.90    52 Week High $45.58 
Open $50.11    52 Week Low $37.82 
Day High $50.47    P/E N/A 
Day Low $49.86    EPS $0.00 
Volume 4,093,343       

InterMune, Inc. (NASDAQ: ITMN) Delayed: 73.89 --0 (-0%)
Previous Close $73.89    52 Week High $74.24 
Open $1.07    52 Week Low $10.95 
Day High $73.89    P/E N/A 
Day Low $73.89    EPS $-2.67 
Volume      

NOVARTIS AG (NYSE: NVS) Delayed: 152.32 -2.29 (1.48%)
Previous Close $154.61    52 Week High $89.15 
Open $152.03    52 Week Low $69.84 
Day High $153.43    P/E N/A 
Day Low $151.82    EPS $0.00 
Volume 2,470,642